Isabel Pimentel

Home Tag

Balmaña - Pimentel VHIO

RADIOLA study identifies a new complementary biomarker to distinguish which metastatic gBRCA, HER2- breast cancer patients are molt likely to respond up to 7 times more to olaparib.

Promoted by SOLTI and developed in scientific collaboration with the Vall d’Hebron Institute of Oncology (VHIO), the SOLTI-1910 RADIOLA study…